J. Anim Sci.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Capshaw, E. L.
Right arrow Articles by French, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capshaw, E. L.
Right arrow Articles by French, D. D.

Journal of Animal Science, Vol 79, Issue 12 3137-3147, Copyright © 2001 by American Society of Animal Science

EVALUATION STUDIES

Daily treatment of horses with equine somatotropin from 4 to 16 months of age

E. L. Capshaw, D. L. Thompson Jr, K. M. Kulinski, C. A. Johnson and D. D. French
Department of Animal Science, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, Baton Rouge 70803, USA.

Fourteen foals between 4 and 4.5 mo of age were used to determine the effects of 12 mo of daily treatment with equine somatotropin (eST) on growth, metabolic, and hormonal characteristics. The foals were paired by sex, type, and lineage, and one of each pair was administered eST daily at 20 microg/kg of BW. Body weights, body measurements, and assessments of glucose tolerance and feedback effects on endogenous somatotropin (ST) secretion were made routinely. Treatment with eST did not alter (P > 0.10) BW, height at withers, length of body, widths of chest and rump, heart girth, length of head, front or rear cannon lengths, front or rear cannon circumferences, gaskin circumference, or skin thickness, even though plasma IGF-I concentrations were doubled (P = 0.012). Glucose concentrations were higher (P = 0.03) in treated horses before glucose infusion; there was no difference (P > 0.10) in the glucose response to infusion. The insulin response to glucose infusion in the treated horses was generally higher (P = 0.0069) than in controls. Endogenous ST secretion in response to a ST secretagogue was reduced (P = 0.0001) in foals treated with eST in all months. The prolactin and thyroid-stimulating hormone responses to thyrotropin-releasing hormone on June 1 were not affected (P > 0.10) by treatment. In conclusion, daily treatment of growing horses with eST for 12 mo at the recommended dose altered the hormonal and metabolic characteristics known to be affected by ST but did not alter the growth characteristics of the animals.


This article has been cited by other articles:


Home page
 Vet Rec.Home page
E. de Graaf-Roelfsema, W. Back, H. A. Keizer, T. A. E. Stout, and J. H. van der Kolk
Normal function of the hypothalamic-pituitary growth axis in three dwarf Friesian foals
Vet Rec., September 26, 2009; 165(13): 373 - 376.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
J. A. Cartmill, D. L. Thompson Jr., W. A. Storer, L. R. Gentry, and N. K. Huff
Endocrine responses in mares and geldings with high body condition scores grouped by high vs. low resting leptin concentrations
J Anim Sci, September 1, 2003; 81(9): 2311 - 2321.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
L. R. Gentry, D. L. Thompson Jr., G. T. Gentry Jr., K. A. Davis, and R. A. Godke
High versus low body condition in mares: Interactions with responses to somatotropin, GnRH analog, and dexamethasone
J Anim Sci, December 1, 2002; 80(12): 3277 - 3285.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Animal Science.